OTHER INFORMATION
−Removed: During the three months ended June 30, 2025 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
+Added: During the three months ended September 30, 2025 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
+Added: On July 11, 2025, two short term promissory notes of $150 thousand each were issued by the Company’s majority-owned subsidiary KardioNav to David Jenkins, the Company's Chairman of the Board and Chief Executive Officer, and Lifestim, Inc., a company controlled by Mr.
+Added: Jenkins, in exchange for an aggregate loan of $300 thousand.
+Added: The promissory notes have a maturity date of July 11, 2026, and interest rates of 4.2% per annum, with all principal and interest payable upon maturity.
+Added: As of September 30, 2025, $300 thousand of principal was outstanding on the notes.
+Added: The notes, including all principal and interest, accelerate and become immediately due and payable upon the occurrence of certain customary events of default, including failure to pay amounts owed when due, material breach of the Company’s representations or warranties (unless waived by the holders or cured within 10 days following notice), certain events involving the discontinuation of the Company’s business and/or certain types of proceedings involving insolvency, bankruptcy, receivership and the like.
Incorporated by Reference
−Removed: Asset Purchase Agreement dated April 22, 2025 by and between the Company and Cardionomic (assignment for the benefit of creditors), LLC
Amended and Restated Certificate of Incorporation of the Registrant.
7 unchanged sentences
Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 1/13/2025)
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 8/15/2025)
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 10/17/2025)
Certificate of Designation of Series X Convertible Preferred Stock.
16 unchanged sentences
Form of Series L Warrant offered in May 2025.
−Removed: Amendment to Investment Banking Agreement dated as of April 16, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
−Removed: At the Market Offering Agreement dated as of May 19, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
−Removed: Securities Purchase Agreement dated May 12, 2025
−Removed: Registration Rights Agreement dated May 12, 2025
−Removed: Assignment Agreement dated May 12, 2025
−Removed: Investment Banking Agreement dated February 11, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
+Added: Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc.
+Added: Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc.
+Added: and Lifestim, Inc.
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
CATHETER PRECISION, INC.
−Removed: August 11, 2025
+Added: November 13, 2025
Executive Chairman of the Board and
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 11, 2025
+Added: November 13, 2025
/s/ Philip Anderson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.